HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $84.73 billion. The enterprise value is $125.41 billion.
| Market Cap | 84.73B |
| Enterprise Value | 125.41B |
Important Dates
The last earnings date was Friday, April 26, 2024, before market open.
| Earnings Date | Apr 26, 2024 |
| Ex-Dividend Date | Jun 14, 2024 |
Share Statistics
HCA Healthcare has 261.91 million shares outstanding. The number of shares has decreased by -4.61% in one year.
| Shares Outstanding | 261.91M |
| Shares Change (YoY) | -4.61% |
| Shares Change (QoQ) | -1.15% |
| Owned by Insiders (%) | 27.47% |
| Owned by Institutions (%) | 64.17% |
| Float | 188.73M |
Valuation Ratios
The trailing PE ratio is 16.13 and the forward PE ratio is 15.15. HCA Healthcare's PEG ratio is 1.44.
| PE Ratio | 16.13 |
| Forward PE | 15.15 |
| PS Ratio | 1.27 |
| Forward PS | 1.20 |
| PB Ratio | n/a |
| P/FCF Ratio | 15.57 |
| PEG Ratio | 1.44 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.25, with an EV/FCF ratio of 23.09.
| EV / Earnings | 22.93 |
| EV / Sales | 1.88 |
| EV / EBITDA | 10.25 |
| EV / EBIT | 13.75 |
| EV / FCF | 23.09 |
Financial Position
The company has a current ratio of 1.16
| Current Ratio | 1.16 |
| Quick Ratio | 0.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.44 |
| Debt / FCF | 7.75 |
| Interest Coverage | 4.63 |
Financial Efficiency
Return on equity (ROE) is -267.80% and return on invested capital (ROIC) is 18.43%.
| Return on Equity (ROE) | -267.80% |
| Return on Assets (ROA) | 9.90% |
| Return on Capital (ROIC) | 18.43% |
| Revenue Per Employee | $215,213 |
| Profits Per Employee | $17,645 |
| Employee Count | 310,000 |
| Asset Turnover | 1.21 |
| Inventory Turnover | 20.19 |
Taxes
In the past 12 months, HCA Healthcare has paid $1.68 billion in taxes.
| Income Tax | 1.68B |
| Effective Tax Rate | 23.51% |
Stock Price Statistics
The stock price has increased by +16.49% in the last 52 weeks. The beta is 1.67, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (1Y) | 1.67 |
| 52-Week Price Change | +16.49% |
| 50-Day Moving Average | 320.83 |
| 200-Day Moving Average | 281.62 |
| Relative Strength Index (RSI) | 54.34 |
| Average Volume (30 Days) | 1,032,429 |
Short Selling Information
The latest short interest is 2.48 million, so 0.95% of the outstanding shares have been sold short.
| Short Interest | 2.48M |
| Short Previous Month | 2.60M |
| Short % of Shares Out | 0.95% |
| Short % of Float | 1.31% |
| Short Ratio (days to cover) | 2.15 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $66.72 billion and earned $5.47 billion in profits. Earnings per share was $20.03.
| Revenue | 66.72B |
| Gross Profit | 26.46B |
| Operating Income | 9.75B |
| Pretax Income | 7.15B |
| Net Income | 5.47B |
| EBITDA | 12.24B |
| EBIT | 9.12B |
| Earnings Per Share (EPS) | $20.03 |
Balance Sheet
The company has $1.28 billion in cash and $42.10 billion in debt, giving a net cash position of -$40.82 billion or -$155.85 per share.
| Cash & Cash Equivalents | 1.28B |
| Total Debt | 42.10B |
| Net Cash | -40.82B |
| Net Cash Per Share | -$155.85 |
| Equity / Book Value | -1.62B |
| Book Value Per Share | -6.17 |
| Working Capital | 2.14B |
Cash Flow
In the last 12 months, operating cash flow was $10.10 billion and capital expenditures -$4.67 billion, giving a free cash flow of $5.43 billion.
| Operating Cash Flow | 10.10B |
| Capital Expenditures | -4.67B |
| Free Cash Flow | 5.43B |
| FCF Per Share | $20.54 |
Margins
Gross margin is 39.65%, with operating and profit margins of 14.62% and 8.20%.
| Gross Margin | 39.65% |
| Operating Margin | 14.62% |
| Pretax Margin | 10.72% |
| Profit Margin | 8.20% |
| EBITDA Margin | 18.34% |
| EBIT Margin | 13.67% |
| FCF Margin | 8.14% |
Dividends & Yields
This stock pays an annual dividend of $2.64, which amounts to a dividend yield of 0.82%.
| Dividend Per Share | $2.64 |
| Dividend Yield | 0.82% |
| Dividend Growth (YoY) | 8.62% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 13.18% |
| Buyback Yield | 4.61% |
| Shareholder Yield | 5.42% |
| Earnings Yield | 6.47% |
| FCF Yield | 6.42% |
Analyst Forecast
The average price target for HCA Healthcare is $318.81, which is -1.50% lower than the current price. The consensus rating is "Buy".
| Price Target | $318.81 |
| Price Target Difference | -1.50% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 5.82% |
| EPS Growth Forecast (5Y) | 10.28% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.63 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.63 |
| Piotroski F-Score | 7 |